Enhanced human adipose‐derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Kaixiang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiothoracic Surgery, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, Chin…. Hauptthemen laut MEDLINE: Myocardial Infarction, Fibroblast Growth Factor 2, Vascular Endothelial Growth Factor A, Stem Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, JINYE ZHONGZI Project from SCMC-HN, Shanghai Key Research Center Construction Project-Shanghai Research Center for Pediatric Cardiovascular Diseases.
Abstract (Originalsprache)
Mesenchymal stem cell therapy involves the secretion of various factors to regulate the local microenvironment in various of diseases. This therapy offers hope for treating acute myocardial infarction (MI), which poses a serious threat to human health. However, challenges such as low paracrine efficiency and poor cell survival persist due to the harsh post‐infarction conditions, such as hypoxia. Recently, enhanced cell therapy, in which vascular endothelial growth factor A (VEGFA) and basic fibroblast growth factor (bFGF) are used as therapeutic agents to limit myocardial injury and simultaneously induce neovascularisation, has been recognised as a promising new strategy to improve the efficacy of cell therapy. Chemically synthetic modified messenger RNA (modRNA), a novel protein expression technology, enables safe, rapid, efficient and pulsatile expression of target proteins in vivo and in vitro settings. It has been widely applied in the fields of vaccine research and tissue regeneration. In this study, human adipose‐derived stem cells (hADSCs) were transfected with VEGFA and bFGF modRNA to transiently overexpress these proteins before transplantation. This modification enhanced the paracrine effect of transplanted hADSCs and promoted stability in the vascular network at the transplantation site. Overexpression of VEGFA and bFGF in hADSCs not only inhibited apoptosis but also reduced ventricular remodelling and improved cardiac function and left ventricular conduction. Overall, the additive effects of VEGFA modRNA, bFGF modRNA and hADSCs hold promise for comprehensive cardiac repair post‐MI and show substantial potential for treating ischemic heart diseases. Key points ModRNAs‐transfected hADSCs exhibit pulsed and transient expression, enabling efficient production of functional VEGFA and bFGF proteins. Intracardiac injection of these engineered hADSCs leads to the enhancement of cardiac function and the improvement of electrical conduction. The hADSCs dual mainly exerts its effect on myocardial infarction by promoting stable vascular regeneration and suppressing cell apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Cardiothoracic Surgery, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute of Electrophysiology, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
- Henan Key Laboratory of Cardiac Electrophysiology, Henan SCOPE Research Institute of Electrophysiology Co. Ltd., Kaifeng, China.
- School of Mathematical Sciences, Institute of Natural Sciences, and MOE-LSC, Shanghai Jiao Tong University, Shanghai, China.
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute of Pediatric Translational Medicine, Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Wei Fu
Förderung
- National Natural Science Foundation of China
- JINYE ZHONGZI Project from SCMC-HN
- Shanghai Key Research Center Construction Project-Shanghai Research Center for Pediatric Cardiovascular Diseases
- Key Laboratory of Infection and Immunity of Anhui Higher Education Institutes, Bengbu Medical College
Zitieren
APA
Li, K., Luo, R., Yu, X., Dong, W., Hao, G., Hu, D., Yu, Z., Liu, M., Lu, T., Wang, X., Tang, X., Lin, X., Wang, H., Wang, W., & Fu, W. (2025). Enhanced human adipose‐derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70250
Vancouver
Li K, Luo R, Yu X, Dong W, Hao G, Hu D, et al. Enhanced human adipose‐derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70250
BibTeX
@article{Li2025,
author = {Li, Kaixiang and Luo, Runjiao and Yu, Xindi and Dong, Wei and Hao, Guoliang and Hu, Dan and Yu, Ziyou and Liu, Minglu and Lu, Tingting and Wang, Xiangying and Tang, Xin and Lin, Xinjun and Wang, Huijing and Wang, Wei and Fu, Wei},
title = {Enhanced human adipose‐derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70250}
}
EUVIMED